Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Pediatric core set criteria for improvement in juvenile idiopathic arthritis

From: Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis

1. Physician's global assessment of overall disease activity
2. Parent of patient global assessment of overall well-being
3. Functional ability
4. Number of joints with active arthritis
5. Number of joints with limited range of motion
6. Erythrocyte sedimentation rate
American College of Rheumatology Pediatric 30 response A minimum of 30% improvement from baseline in a minimum of three out of six components, with a worsening by >30% in no more than one component
American College of Rheumatology Pediatric 50 response Requires 50% improvement in three out of six components with worsening of 30% in no more than one component
American College of Rheumatology Pediatric 70 response Requires 70% improvement in three out of six components with worsening of 30% in no more than one component
  1. Data from Giannini and colleagues [50] and Brunner and colleagues [51].